Japanese Structure Survey of Radiation Oncology in 2011.


Journal

Journal of radiation research
ISSN: 1349-9157
Titre abrégé: J Radiat Res
Pays: England
ID NLM: 0376611

Informations de publication

Date de publication:
22 Nov 2019
Historique:
received: 19 03 2019
revised: 28 04 2019
accepted: 19 07 2019
pubmed: 31 10 2019
medline: 24 4 2020
entrez: 31 10 2019
Statut: ppublish

Résumé

We evaluated the evolving structure of radiation oncology in Japan in terms of equipment, personnel, patient load and geographic distribution to identify and overcome any existing limitations. From March 2012 to August 2015, the Japanese Society for Radiation Oncology conducted a questionnaire based on the Japanese national structure survey of radiation oncology in 2011. Data were analyzed based on the institutional stratification by the annual number of new patients treated with radiotherapy per institution. The estimated annual numbers of new and total (new plus repeat) patients treated with radiation were 211 000 and 250 000, respectively. Additionally, the estimated cancer incidence was 851 537 cases with approximately 24.8% of all newly diagnosed patients being treated with radiation. The types and numbers of treatment devices actually used included linear accelerator (LINAC; n = 836), telecobalt (n = 3), Gamma Knife (n = 46), 60Co remote afterloading system (RALS; n = 24), and 192Ir RALS (n = 125). The LINAC system used dual-energy functions in 619 units, 3D conformal radiotherapy functions in 719 and intensity-modulated radiotherapy (IMRT) functions in 412. There were 756 JRS or JASTRO-certified radiation oncologists, 1018.5 full-time equivalent (FTE) radiation oncologists, 2026.7 FTE radiotherapy technologists, 149.1 FTE medical physicists, 141.5 FTE radiotherapy quality managers and 716.3 FTE nurses. The frequency of IMRT use significantly increased during this time. To conclude, although there was a shortage of personnel in 2011, the Japanese structure of radiation oncology has clearly improved in terms of equipment and utility.

Identifiants

pubmed: 31665374
pii: 5607837
doi: 10.1093/jrr/rrz058
pmc: PMC7357227
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

786-802

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.

Références

Cancer. 2002 Jul 1;95(1):164-71
pubmed: 12115330
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):e111-7
pubmed: 21470792
J Radiat Res. 2019 Jan 1;60(1):80-97
pubmed: 30137391
Int J Clin Oncol. 2009 Jun;14(3):237-44
pubmed: 19593616
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1472-6
pubmed: 16029809
Jpn J Clin Oncol. 2005 Sep;35(9):497-506
pubmed: 16120622
Strahlenther Onkol. 2011 Mar;187(3):167-74
pubmed: 21347636
J Radiat Res. 2012 Sep;53(5):710-21
pubmed: 22843366
Int J Clin Oncol. 2013 Oct;18(5):775-83
pubmed: 23053398
Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):144-52
pubmed: 18374515

Auteurs

Hodaka Numasaki (H)

Department of Functional Diagnostic Science, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita-shi, Osaka, 565-0871, Japan.

Teruki Teshima (T)

Department of Radiation Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka-shi, Osaka, 541-8567, Japan.

Tetsuo Nishimura (T)

Division of Radiation Oncology, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Keizo Akuta (K)

Department of Radiology, Japanese Red Cross Otsu Hospital, 1-1-35 Nagara, Otsu-shi, Siga, 520-0000, Japan.

Yutaka Ando (Y)

Department of Radiation Oncology, Saitama Medical Center, 4-9-3 Kitaurawa, Urawa-ku, Saitama-shi, Saitama, 330-0074, Japan.

Hiroshi Ikeda (H)

Department of Radiation Oncology, Sakai City Medical Center, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai-shi, Osaka, 593-8304, Japan.

Norihiko Kamikonya (N)

Department of Radiology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya-shi, Hyogo, 663-8501, Japan.

Masahiko Koizumi (M)

Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita-shi, Osaka, 565-0871, Japan.

Tomonari Sasaki (T)

Division of Medical Quantum Science, Department of Health Sciences, Kyushu University Faculty of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, 812-8582, Japan.

Kenji Sekiguchi (K)

Sonoda-kai Radiation Oncology Clinic, 3-4-19 Hokima, Adachi-ku, Tokyo, 121-0064, Japan.

Masao Tago (M)

Department of Radiology, Teikyo University Mizonokuchi Hospital, 5-1-1 Futako, Takatsu, Kawasaki-shi, Kanagawa, 213-8507, Japan.

Atsuro Terahara (A)

Department of Radiology, Toho University Omori Medical Center, 6-11-1 Omori-nishi, Ota-ku, Tokyo, 143-8541, Japan.

Katsumasa Nakamura (K)

Department of Radiation Oncology, Hamamatsu University Hospital, 1-20-1 Handayama, Higashi-ku, Hamamatsu-shi, Shizuoka, 431-3192, Japan.

Masamichi Nishio (M)

Hokkaido Cancer Center, 2-3-54 Kikusui 4jyo, Shiraishi-ku, Sapporo-shi, Hokkaido, 003-0804, Japan.

Masao Murakami (M)

Southern TOHOKU Proton Therapy Center, 172-7 Yatsuyamada, Koriyama-shi, Fukushima, 963-8563, Japan.

Yoshimasa Mori (Y)

Department of Radiology and Radiation Oncology, Aichi Medical University, 1-1 Yazakokarimata, Nagakute-shi, Aichi, 480-1195, Japan.

Kazuhiko Ogawa (K)

Department of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka, 565-0871, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH